Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies

Abstract

Globally, malignancies cause one out of six mortalities, which is a serious health problem. Cancer therapy has always been challenging, apart from major advances in immunotherapies, stem cell transplantation, targeted therapies, hormonal therapies, precision medicine, and palliative care, and traditional therapies such as surgery, radiation therapy, and chemotherapy. Natural products are integral to the development of innovative anticancer drugs in cancer research, offering the scientific community the possibility of exploring novel natural compounds against cancers. The role of natural products like Vincristine and Vinblastine has been thoroughly implicated in the management of leukemia and Hodgkin’s disease. The computational method is the initial key approach in drug discovery, among various approaches. This review investigates the synergy between natural products and computational techniques, and highlights their significance in the drug discovery process. The transition from computational to experimental validation has been highlighted through in vitro and in vivo studies, with examples such as betulinic acid and withaferin A. The path toward therapeutic applications have been demonstrated through clinical studies of compounds such as silvestrol and artemisinin, from preclinical investigations to clinical trials. This article also addresses the challenges and limitations in the development of natural products as potential anti-cancer drugs. Moreover, the integration of deep learning and artificial intelligence with traditional computational drug discovery methods may be useful for enhancing the anticancer potential of natural products.

Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies

“…Computational modeling and bioinformatics analyses play a pivotal role in optimizing the design and implementation of precision nanomedicine, facilitating a deeper understanding of the complex interactions between nanoparticles and the intricate molecular landscape of colorectal cancer. 225 Computational modeling serves as a powerful tool in predicting and optimizing the behavior of nanoparticles within the biological milieu. Molecular dynamics simulations, for instance, allow researchers to explore the dynamic interactions between nanoparticles and biological components at the atomic level.…”

“…Nanomedicine, with its targeted drug delivery systems and diagnostic platforms, presents an innovative avenue for personalized treatment strategies. Computational modeling and bioinformatics analyses play a pivotal role in optimizing the design and implementation of precision nanomedicine, facilitating a deeper understanding of the complex interactions between nanoparticles and the intricate molecular landscape of colorectal cancer …”

Potential of MMP-2 and MMP-9 Gelatinase Blockade as a Therapeutic Strategy in Fibrosarcoma Treatment: A Decadal Review

“…Inhibited MMP-9 more efficiently than a naturally occurring MMP inhibitor, tetracycline; dose-dependently inhibits proliferation of fibrosarcoma HT-1080 cells search focuses on isolating new compounds, understanding their mechanisms, and developing ways to synthesize them efficiently and test them in clinical settings. This field holds a promising avenue for the discovery of novel therapies that can contribute to cancer treatment [46]. Natural-based anticancer compounds have garnered interest for their potential in treating various types of cancer, including fibrosarcoma (Table 1).…”

Historical Perspective and Current Trends in Anticancer Drug Development

“…The healing properties of medical plants have been known in traditional medicine for centuries. Natural substances that are present in fruit, vegetables, herbs, and spices have been used in ancient Arabian, Indian, and Chinese cultures as remedies for various ailments including cancer [15].…”